For Qualified Business & Research Customers Only
Pioneer/ Bio
Catalog/PB-087
PB-087Purity on request
Fig. · White to beige powder (lyophilized)

Metabolic Research Peptides

Lixisenatide

C₂₁₅H₃₄₇N₆₁O₆₅S · 4858.49 g/mol

Lixisenatide is a synthetic GLP-1-receptor agonist peptide derived from exendin-4. Research applications include postprandial glucose-regulation studies, gastric-emptying-delay research, appetite-modulation studies, and pancreatic β-cell proliferation and apoptosis-related research.

Purity
On request
Quantity
Milligram, gram, or bulk quantities
Documentation
COA, HPLC, MS / LC-MS, SDS
Packaging
Bulk, non-branded, or private label

Research Use Only · Buyer verification required

Specifications

Technical profile.

Catalog Number
PB-087
CAS Number
320367-13-3
Sequence
H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH₂
Molecular Formula
C₂₁₅H₃₄₇N₆₁O₆₅S
Molecular Weight
4858.49 g/mol
Purity (HPLC)
Available specifications confirmed with quotation
Appearance
White to beige powder (lyophilized)
Vial Size
Confirmed with quotation
Storage
2–8 °C, sealed, desiccated
Reconstitution
Bacteriostatic water
Classification
Research Use Only

Documentation & Quality

What documentation may be available for Lixisenatide.

Lixisenatide·PB-087
Certificate of Analysis (COA)
Manufacturing partner or independent summary of identity, purity, and other release testing for a batch.
Pending Verified Documentation
HPLC Chromatogram
Chromatographic data supporting the purity result reported for a batch.
Pending Verified Documentation
Mass Spectrometry (MS) Report
Mass spectrometry data supporting molecular identity confirmation.
Pending Verified Documentation
Endotoxin Test
Endotoxin testing result, where applicable to the product and its intended use.
Pending Verified Documentation
Safety Data Sheet (SDS)
Handling, storage, and safety information for the material.
Pending Verified Documentation
Third-Party Laboratory Report
Testing performed by an independent laboratory, separate from the manufacturing partner's own QC.
Pending Verified Documentation

Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.

Request a Quote

Request a Quote

Inquire about pricing and availability.

Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.

Request a Quote
Inquire about Lixisenatide (PB-087)
Documentation requested